FAMILY PLANNING MINIMUM REQUIREMENTS

Nexplanon (etonogestrel (ENG) 68 mg subdermal implant) was the comparator. Protocol 14371 was a multicentre, open label, single group study up to 1 year LCS12 of 12 months duration with an optional extension up to 3 years. ................
................